Patent: 7,507,873
✉ Email this page to a colleague
Summary for Patent: 7,507,873
Title: | Transgenic avians containing recombinant ovomucoid promoters |
Abstract: | Transgenic avians having a recombinant ovomucoid gene expression controlling region operably linked to one or more useful amino acid coding sequences. |
Inventor(s): | Harvey; Alex J. (Athens, GA), Leavitt; Markley C. (Watkinsville, GA), Wang; Youliang (Monroe, GA) |
Assignee: | AviGenics, Inc. (Athens, GA) |
Application Number: | 11/649,543 |
Patent Claims: | see list of patent claims |
Details for Patent 7,507,873
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Immunex Corporation | ENBREL | etanercept | For Injection | 103795 | 11/02/1998 | ⤷ Try a Trial | 2021-11-30 |
Immunex Corporation | ENBREL | etanercept | For Injection | 103795 | 05/27/1999 | ⤷ Try a Trial | 2021-11-30 |
Immunex Corporation | ENBREL | etanercept | Injection | 103795 | 09/27/2004 | ⤷ Try a Trial | 2021-11-30 |
Immunex Corporation | ENBREL | etanercept | Injection | 103795 | 02/01/2007 | ⤷ Try a Trial | 2021-11-30 |
Immunex Corporation | ENBREL MINI | etanercept | Injection | 103795 | 09/14/2017 | ⤷ Try a Trial | 2021-11-30 |
Immunex Corporation | ENBREL | etanercept | Injection | 103795 | ⤷ Try a Trial | 2021-11-30 | |
Immunex Corporation | ENBREL | etanercept | Injection | 103795 | 03/05/2020 | ⤷ Try a Trial | 2021-11-30 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |